As the UMass Chan mourns the recent death of Michael Green, MD, PhD, two faculty have been appointed to fill positions that Dr. Green nobly held. Jonathan M. Gerber, MD, has been appointed director of the UMass Cancer Center, and Michelle A. Kelliher, PhD, will serve as interim chair of the Department of Molecular, Cell & Cancer Biology.

After college, MD/PhD student Ethan Loew was torn between practicing bench science or becoming a clinician, but his postgraduate experience in a lab and a hospital showed him how he could combine the two.

MassBiologics of UMass Chan Medical School develops novel nanobody as inhalable and affordable medicine against SARS-CoV-2 and emerging variants.

The University of Massachusetts Board of Trustees voted to approve one new endowed chair at UMass Chan Medical School and the appointment of two accomplished faculty members to endowed chairs.

In her lab, Elizabeth Shank, PhD, interprets the chemical language of bacteria with the goal of harnessing its power to potentially developing new antibiotics.

In her preliminary studies, PhD student Megan Honeywell has found that cells can trigger a cell death even when they do not have the p53 protein, the so-called “guardian of the genome.”

UMass Chan faculty in rheumatology, biochemistry & molecular biotechnology and cancer biology are being supported by endowments.

A large, double-blind, randomized controlled trial found that outpatients who received convalescent plasma within nine days of onset of COVID-19 symptoms were significantly less likely to be hospitalized than those who received placebo control plasma.

Read Pukkila-Worley, MD, is a physician-scientist researching how bacteria cause disease and how the immune system detects infection.

Raffi Van Aroian, PhD, studies intestinal parasitic nematodes, or worms, which can seriously impact children. To combat drug resistance, he and colleague Gary R. Ostroff, PhD, are working on a new type of treatment.